| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$126 |
Change in substantial holding - M Azzi
|
31 Jul 2025 12:44PM |
$0.370 |
$0.515 |
risen by
39.19%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$22 |
2025 Q2 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 12:44PM |
$0.325 |
$0.400 |
risen by
23.08%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- ImExHS Limited reported on its quarterly activities and financial results for Q2 2025.
- The company continues to expand its presence in Latin America, the US, and Australia.
- Revenue growth is driven by increased SaaS adoption and new customer contracts.
- Significant progress was made in cost management and operational efficiency.
- New business partnerships and contracts were secured during the quarter.
- Product development and strategic initiatives remain a focus to support future growth.
- Cash receipts from customers increased compared to previous quarters.
- The financial report includes a summary of cash flows and an outlook for continued growth.
- The company remains committed to enhancing its radiology and medical imaging solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hastings Technology Metals Limited (HAS) ORDINARY FULLY PAID |
Materials |
$101 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 12:43PM |
$0.285 |
$0.455 |
risen by
59.65%
|
|
HAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Hastings Technology Metals Limited continued advancing the Yangibana Rare Earths Project in Western Australia during the quarter.
- Key activities included progress in engineering, procurement, and construction planning for the Yangibana Project, as well as the progression of long lead item procurement.
- The company focused on financing initiatives, including pursuing debt funding and potential strategic partnerships.
- A binding Share Sale and Purchase Agreement was executed to acquire 100% of the Yangibana Project’s Bald Hill and Fraser’s deposits from a joint venture partner, further consolidating project ownership.
- Exploration activities targeted resource extension and development drilling, with positive results reported.
- Hastings continued engagement with government and regulatory bodies, achieving milestones in environmental and project permitting.
- Cash flow for the quarter included significant project development and exploration expenditure, as detailed in the Appendix 5B report.
- At the end of the quarter, Hastings reported a strong cash position to support ongoing development activities.
- No production or sales revenue was generated during the quarter as the Yangibana Project remains in the development phase.
- The Appendix 5B provides a summary of cash flows, including operating, investing, and financing activities for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 12:43PM |
$0.034 |
$0.021 |
fallen by
38.24%
|
|
ABE - Price-sensitive ASX Announcement
Full Release
Key Points
- ABE is committed to democratizing bond market access for retail and wholesale investors.
- A new retail bond trading platform was successfully launched during the quarter.
- Enhancements were made to the company’s digital infrastructure and product offerings.
- Ongoing constructive engagement with the Australian Securities & Investments Commission (ASIC) regarding regulatory approvals and compliance.
- Operational updates include increased client onboarding and adoption of digital platform.
- ABE continues to focus on expanding its distribution network via partnerships and alliances.
- The Appendix 4C details cash inflows and outflows, showing ongoing investment in technology and business development.
- The company has managed expenses carefully while seeking new opportunities for growth.
- Funding arrangements and related party transactions are disclosed in the report.
- The outlook section emphasizes continued platform development, business expansion, and strategic initiatives for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$63 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 12:40PM |
$0.510 |
$0.340 |
fallen by
33.33%
|
|
MTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report covers the period ending 31 December 2023.
- Focus on exploration at the Copalquin Gold Silver District in Mexico.
- Drilling and technical studies conducted at La Soledad, El Refugio, and El Cometa.
- Metallurgical testing confirmed high gold and silver recoveries.
- Resource expansion and infill drilling programs progressed.
- Environmental and community engagement activities continued.
- Appendix 5B Cash Flow Report demonstrates prudent cash management.
- Company maintained sufficient cash reserves to support operations.
- MTH continues to manage expenditure carefully in response to market conditions.
- Plans for further drilling and technical work in 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$63 |
Application for quotation of securities - MTH
|
31 Jul 2025 12:34PM |
$0.510 |
$0.340 |
fallen by
33.33%
|
|
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$63 |
Cancel - Notification regarding unquoted securities - MTH
|
31 Jul 2025 12:31PM |
$0.510 |
$0.340 |
fallen by
33.33%
|
|
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$173 |
Quarterly Report - April to June 2025
|
31 Jul 2025 12:29PM |
$0.079 |
$0.095 |
risen by
20.25%
|
|
TER - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly operational and financial results presented for April to June 2025.
- Production and sales performance reviewed for all major assets.
- Discussion of market conditions, including coal pricing and demand.
- Cost management strategies implemented to counteract market volatility.
- Financial overview includes revenue, profit margins, and cash flow analysis.
- Regulatory and compliance updates provided.
- Safety and environmental performance highlighted, with mention of initiatives undertaken.
- Updates on key projects and development activities.
- Board and management commentary on current performance and future outlook.
- Commitment to shareholder value amid ongoing market challenges reiterated.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$170 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 12:27PM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
RNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued advancement of the Siviour BAM project in South Australia.
- Obtained key regulatory and environmental approvals for the Siviour project.
- Progress in offtake and financing discussions, including with the Australian Government’s Critical Minerals Facility.
- Cash outflows mainly directed towards exploration, evaluation, and project development.
- Strong focus on developing a vertically integrated graphite operation.
- Engagement with potential customers and partners for graphite offtake.
- Positioning to capitalize on increasing demand for battery anode materials.
- Appendix 5B Cash Flow Report details cash receipts, outflows, and financial position.
- Updates on other graphite and mineral exploration activities.
- No mining production or development activities occurred during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sayona Mining Limited (SYA) ORDINARY FULLY PAID |
Materials |
- |
Results of 2025 Extraordinary General Meeting
|
31 Jul 2025 12:26PM |
$0.022 |
$3.440 |
risen by
15,536.36%
|
|
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$778 |
Daily Net Tangible Asset Statement
|
31 Jul 2025 12:25PM |
$1.185 |
$1.065 |
fallen by
10.13%
|
|
| MFF Capital Investments Limited (MFF) ORDINARY FULLY PAID |
Financials |
$2,687 |
Notice of Full Year Results Briefing
|
31 Jul 2025 12:23PM |
$4.600 |
$4.560 |
fallen by
0.87%
|
|
| Victor Group Holdings Limited (VIG) ORDINARY FULLY PAID |
Information Technology |
$31 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 12:21PM |
$0.047 |
$0.041 |
fallen by
12.77%
|
|
VIG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ended 31 December 2023
- Company shares remain suspended from ASX since August 2022
- Review and assessment of potential new business opportunities ongoing
- Active discussions with several third parties regarding potential transactions
- Main cash outflows related to administrative and corporate costs
- No revenue-generating operations during the period
- Company continues to seek a suitable business acquisition to enable relisting
- Board and management remain focused on preserving cash while seeking opportunities
- No acquisitions completed as of the report date
- Relisting of securities dependent on completing and announcing a suitable transaction
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindsay Australia Limited (LAU) ORDINARY FULLY PAID |
Industrials |
$228 |
Notification of cessation of securities - LAU
|
31 Jul 2025 12:20PM |
$0.738 |
$0.625 |
fallen by
15.25%
|
|
| Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$170 |
Completion of Bulk Sample Production - Updated Announcement
|
31 Jul 2025 12:20PM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
| Austco Healthcare Limited (AHC) ORDINARY FULLY PAID |
Health Care |
$144 |
Application for quotation of securities - AHC
|
31 Jul 2025 12:20PM |
$0.370 |
$0.385 |
risen by
4.05%
|
|
| Aquirian Limited (AQN) ORDINARY FULLY PAID |
Industrials |
$43 |
Notification of cessation of securities - AQN
|
31 Jul 2025 12:07PM |
$0.335 |
$0.410 |
risen by
22.39%
|
|
| Australian Pacific Coal Limited (AQC) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities and Cashflow Reports
|
31 Jul 2025 12:06PM |
$0.012 |
$0.007 |
fallen by
45.83%
|
|
AQC - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities and cashflow for the period ending 31 December 2023.
- Australian Pacific Coal Limited (AQC) continues operations at the Dartbrook Coal Mine.
- Production, sales volumes and operational performance for the quarter are reported.
- Cash receipts and payments, including operational and capital expenditure, are detailed.
- Significant business developments during the quarter are outlined.
- Regulatory and compliance updates relevant to the company's operations are included.
- Forward-looking statements discuss risks, opportunities, and strategic plans.
- The report provides a summary of financial position and liquidity.
- Emphasis on ongoing project development, operational optimisations, and stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$9 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 12:06PM |
$0.025 |
$0.035 |
risen by
40%
|
|
ALV - Price-sensitive ASX Announcement
Full Release
Key Points
- Alvo Minerals Limited completed a maiden JORC Mineral Resource Estimate at the C3 deposit of the Palma Project in Brazil.
- Metallurgical testwork and environmental baseline studies were advanced to support future project development and permitting.
- Regional exploration efforts included target generation and drilling with the aim of discovering additional mineralized zones.
- The company maintained a robust cash position and demonstrated prudent financial management as detailed in the Appendix 5B Cash Flow Report.
- Key expenditures during the quarter were focused on exploration, technical studies, and advancing permitting processes.
- Alvo continued to engage with stakeholders and progress commercial and technical strategies to maximize shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Swift Networks Group Limited (SW1) ORDINARY FULLY PAID |
Communication Services |
$11 |
Notification of Investor briefing
|
31 Jul 2025 12:02PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
| Swift Networks Group Limited (SW1) ORDINARY FULLY PAID |
Communication Services |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 12:00PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
SW1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C Cash Flow Report released for the quarter ended 30 June 2023
- Continued focus on strategic transformation and business stabilization
- Growth in recurring revenue streams and new contract wins, particularly in the resources sector
- Improvements in customer retention and operational efficiency
- Disciplined cost control and cash management initiatives implemented
- Stronger balance sheet despite ongoing industry headwinds
- Initiatives underway to diversify revenue streams and optimize operating models
- Investment in technology and service innovation to support long-term growth
- Appendix 4C details cash flows and reaffirms commitment to prudent financial management
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:59AM |
$0.014 |
$0.007 |
fallen by
50%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Cann Group Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- The company reported cash receipts from customers of $4.7 million, an increase from the previous quarter.
- Cann Group completed a $10.2 million placement and share purchase plan to strengthen its balance sheet.
- Operational highlights include progress in medicinal cannabis production and continued commercial supply agreements.
- The Mildura facility maintained strong production and operational output, supporting domestic and international sales.
- Research and development activities continued, including pharmaceutical product development and expanded clinical programs.
- Net cash used in operating activities for the quarter was $3.9 million, reflecting ongoing investment in production and R&D.
- The company is pursuing additional cost-saving initiatives and efficiency improvements.
- Cash at the end of the quarter was $11.2 million, up from $5.1 million at the end of December 2023.
- No payments were made to related parties or their associates except for remuneration as disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasman Resources Limited (TAS) ORDINARY FULLY PAID |
Materials |
$25 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 11:59AM |
$0.015 |
$0.056 |
risen by
273.33%
|
|
TAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers operations for the March 2023 quarter.
- Exploration activities focused on the Lake Torrens Project.
- No significant exploration activities at other projects during the quarter.
- Administrative and corporate developments are summarized.
- Cash flow report (Appendix 5B) outlines receipts, payments, and movements in cash.
- Expenditure mainly related to exploration and evaluation activities.
- The company ended the quarter with a cash balance of approximately $1.8 million.
- No substantial financing or investing cash flows reported during the quarter.
- Tasman Resources remains committed to maintaining exploration and partnership agreements.
- Future plans include ongoing monitoring of expenditure and seeking further opportunities.
- The report confirms compliance with ASX Listing Rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tissue Repair Ltd (TRP) ORDINARY FULLY PAID |
Health Care |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:57AM |
$0.240 |
$0.170 |
fallen by
29.17%
|
|
TRP - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed patient enrollment for Phase III SURF1 clinical trial of TR-987 for chronic wounds
- Ongoing regulatory interactions with relevant authorities for approvals and guidance
- Preparation for top-line data readout from SURF1 study expected in Q2 2024
- Operating cash outflows primarily related to research and development activities
- TRP maintains adequate cash reserves to support planned clinical and operational activities
- Business development efforts continue, including potential partnerships and strategic collaborations
- Declared compliance with ASX Listing Rule 4.7C regarding use of funds
- Forward-looking statements made concerning future milestones and commercialization plans
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,426 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:57AM |
$4.435 |
$3.830 |
fallen by
13.64%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd provided its quarterly activities report and Appendix 4C cash flow report for the quarter ending 31 March 2024.
- The company is advancing clinical trials for its lead product, SAR-bisPSMA (Targeted Copper Theranostic), in the diagnosis and treatment of prostate cancer.
- Key studies mentioned include the CLARIFY Phase III, COBRA Phase II, and SECURE Phase II trials, with progress updates for each.
- Recruitment for patient cohorts in these studies is progressing, with several milestones achieved including near completion of the SECURE dose escalation cohort.
- Clarity has received guidance from the US FDA for the path to potential New Drug Application (NDA) submission for SAR-bisPSMA.
- The company continues to expand its pipeline with additional programs such as SARTATE for neuroblastoma and NETs.
- Financially, the company maintains a strong position with $75.1 million in cash at the end of the quarter.
- Net operating outflows for the quarter were $8.1 million, primarily comprising research and development expenses.
- Clarity does not anticipate the need to raise additional capital in the near term.
- The report provides a detailed summary of cash flows and operational expenses as per the Appendix 4C requirements.
- Strategic partnerships, manufacturing advancements, and regulatory interactions are highlighted as supporting ongoing and future clinical programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
